Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Cyst | 8 | 2024 | 371 | 0.720 |
Why?
|
| Adenocarcinoma, Mucinous | 5 | 2016 | 525 | 0.540 |
Why?
|
| Endosonography | 9 | 2014 | 626 | 0.490 |
Why?
|
| Pancreatic Neoplasms | 12 | 2021 | 5442 | 0.430 |
Why?
|
| Biopsy, Needle | 4 | 2006 | 1623 | 0.220 |
Why?
|
| Papilloma, Intraductal | 1 | 2002 | 21 | 0.210 |
Why?
|
| Biliary Tract Neoplasms | 2 | 2016 | 187 | 0.190 |
Why?
|
| Carcinoma, Papillary | 2 | 2016 | 793 | 0.180 |
Why?
|
| Cystadenoma, Serous | 1 | 2021 | 100 | 0.180 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2001 | 55 | 0.180 |
Why?
|
| Cholestasis | 2 | 2016 | 385 | 0.180 |
Why?
|
| Duodenal Diseases | 1 | 2001 | 101 | 0.180 |
Why?
|
| Pancreaticoduodenectomy | 2 | 2021 | 516 | 0.170 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2016 | 1756 | 0.170 |
Why?
|
| Cholangitis | 1 | 2020 | 110 | 0.160 |
Why?
|
| Pancreatic Ducts | 2 | 2011 | 330 | 0.150 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2007 | 1126 | 0.150 |
Why?
|
| Carcinoembryonic Antigen | 2 | 2016 | 338 | 0.150 |
Why?
|
| Endoscopy, Digestive System | 3 | 2016 | 358 | 0.150 |
Why?
|
| Lower Gastrointestinal Tract | 1 | 2007 | 13 | 0.140 |
Why?
|
| Intestinal Obstruction | 1 | 2001 | 433 | 0.140 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 3 | 2010 | 520 | 0.140 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2007 | 42 | 0.140 |
Why?
|
| Pancreatitis, Chronic | 1 | 2019 | 282 | 0.140 |
Why?
|
| Biopsy, Fine-Needle | 4 | 2014 | 1132 | 0.130 |
Why?
|
| Chromogranins | 1 | 2016 | 160 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 2 | 2011 | 1524 | 0.130 |
Why?
|
| Hiccup | 1 | 2005 | 8 | 0.120 |
Why?
|
| Duodenoscopes | 1 | 2005 | 43 | 0.120 |
Why?
|
| Hypoglycemia | 1 | 2022 | 895 | 0.120 |
Why?
|
| Choledocholithiasis | 1 | 2005 | 50 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2016 | 194 | 0.120 |
Why?
|
| Stents | 2 | 2010 | 3197 | 0.120 |
Why?
|
| Lithotripsy | 1 | 2005 | 137 | 0.120 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2014 | 121 | 0.110 |
Why?
|
| Ampulla of Vater | 1 | 2014 | 150 | 0.110 |
Why?
|
| Mucins | 1 | 2006 | 570 | 0.100 |
Why?
|
| Palliative Care | 3 | 2010 | 3643 | 0.100 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2005 | 247 | 0.100 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2014 | 219 | 0.100 |
Why?
|
| Cystadenocarcinoma, Mucinous | 1 | 2011 | 51 | 0.100 |
Why?
|
| Vomiting | 1 | 2005 | 655 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 1208 | 0.090 |
Why?
|
| Barrett Esophagus | 1 | 2005 | 495 | 0.090 |
Why?
|
| Esophageal Neoplasms | 2 | 2006 | 1668 | 0.090 |
Why?
|
| Esophagus | 2 | 2006 | 1042 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 2204 | 0.090 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2007 | 888 | 0.090 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 6395 | 0.090 |
Why?
|
| Cytodiagnosis | 1 | 2014 | 452 | 0.090 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 1437 | 0.080 |
Why?
|
| Ethanol | 1 | 2005 | 1331 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1767 | 0.080 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 657 | 0.070 |
Why?
|
| Transducers | 1 | 2006 | 243 | 0.060 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 2188 | 0.060 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 13013 | 0.060 |
Why?
|
| Liver | 1 | 2009 | 7578 | 0.050 |
Why?
|
| Adenoma | 1 | 2014 | 2159 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2016 | 2780 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 3 | 2011 | 3620 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2009 | 1836 | 0.050 |
Why?
|
| Middle Aged | 17 | 2022 | 223487 | 0.050 |
Why?
|
| Stomach Neoplasms | 2 | 2006 | 1481 | 0.050 |
Why?
|
| Male | 19 | 2022 | 364731 | 0.050 |
Why?
|
| Retrospective Studies | 10 | 2020 | 81760 | 0.040 |
Why?
|
| Aged | 13 | 2020 | 171502 | 0.040 |
Why?
|
| Candidiasis, Oral | 1 | 2009 | 57 | 0.040 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 59626 | 0.040 |
Why?
|
| Equipment Design | 3 | 2010 | 3522 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2009 | 139 | 0.040 |
Why?
|
| Humans | 25 | 2024 | 768171 | 0.040 |
Why?
|
| Pancreas | 2 | 2021 | 1699 | 0.040 |
Why?
|
| Pancreatitis | 1 | 2004 | 1087 | 0.040 |
Why?
|
| Hemorrhoids | 1 | 2007 | 19 | 0.040 |
Why?
|
| Female | 16 | 2021 | 397187 | 0.030 |
Why?
|
| Angiodysplasia | 1 | 2007 | 22 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2021 | 825 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 39354 | 0.030 |
Why?
|
| Diverticulum | 1 | 2007 | 137 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2009 | 664 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2011 | 14729 | 0.030 |
Why?
|
| Probability | 1 | 2001 | 2479 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 9419 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2014 | 15833 | 0.030 |
Why?
|
| Duodenal Obstruction | 1 | 2005 | 23 | 0.030 |
Why?
|
| Prognosis | 3 | 2014 | 30009 | 0.030 |
Why?
|
| Octreotide | 1 | 2005 | 156 | 0.030 |
Why?
|
| Suction | 1 | 2005 | 268 | 0.030 |
Why?
|
| Amylases | 1 | 2014 | 171 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2005 | 297 | 0.030 |
Why?
|
| Cyst Fluid | 1 | 2014 | 85 | 0.030 |
Why?
|
| Deglutition Disorders | 1 | 2009 | 640 | 0.030 |
Why?
|
| Duodenal Neoplasms | 1 | 2014 | 114 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2005 | 290 | 0.030 |
Why?
|
| Haloperidol | 1 | 2005 | 394 | 0.030 |
Why?
|
| Health Resources | 1 | 2019 | 950 | 0.030 |
Why?
|
| Antiemetics | 1 | 2005 | 188 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2024 | 2523 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2016 | 65379 | 0.030 |
Why?
|
| Adult | 8 | 2019 | 223646 | 0.030 |
Why?
|
| Nausea | 1 | 2005 | 682 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 30237 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2006 | 11244 | 0.020 |
Why?
|
| Recurrence | 2 | 2016 | 8509 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 1744 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2024 | 3620 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2014 | 20762 | 0.020 |
Why?
|
| Emergencies | 1 | 2007 | 1221 | 0.020 |
Why?
|
| Safety | 1 | 2005 | 1159 | 0.020 |
Why?
|
| Length of Stay | 2 | 2019 | 6498 | 0.020 |
Why?
|
| Colectomy | 1 | 2014 | 696 | 0.020 |
Why?
|
| Colitis | 1 | 2007 | 1242 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2001 | 10099 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2011 | 41753 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4120 | 0.020 |
Why?
|
| Weight Loss | 1 | 2009 | 2721 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2005 | 1965 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2005 | 1536 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2006 | 54924 | 0.020 |
Why?
|
| Metals | 1 | 2010 | 713 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 2011 | 788 | 0.020 |
Why?
|
| Young Adult | 3 | 2019 | 60066 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1810 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2014 | 2258 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2008 | 6004 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 20225 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5315 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15869 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12840 | 0.010 |
Why?
|
| Stomach | 1 | 2006 | 701 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2846 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 8741 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2011 | 2235 | 0.010 |
Why?
|
| Lung | 1 | 2009 | 10101 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 6847 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 15453 | 0.010 |
Why?
|
| Hospitalization | 1 | 2019 | 10840 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 89169 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2006 | 2914 | 0.010 |
Why?
|
| Risk Factors | 2 | 2020 | 74944 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 12252 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 36741 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2006 | 3474 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 7243 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 14164 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2004 | 9669 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 24318 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 26379 | 0.000 |
Why?
|
| United States | 1 | 2004 | 73039 | 0.000 |
Why?
|
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_